Logo image of TRX

TRX GOLD CORP (TRX) Stock Fundamental Analysis

NYSEARCA:TRX - NYSE Arca - CA87283P1099 - Common Stock - Currency: USD

0.3152  +0.01 (+2.3%)

After market: 0.3101 -0.01 (-1.62%)

Fundamental Rating

3

TRX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. There are concerns on the financial health of TRX while its profitability can be described as average. TRX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year TRX has reported negative net income.
In the past year TRX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TRX reported negative net income in multiple years.
In multiple years TRX reported negative operating cash flow during the last 5 years.
TRX Yearly Net Income VS EBIT VS OCF VS FCFTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.08%, TRX is in line with its industry, outperforming 52.60% of the companies in the same industry.
With a Return On Equity value of 0.16%, TRX perfoms like the industry average, outperforming 52.60% of the companies in the same industry.
The Return On Invested Capital of TRX (9.83%) is better than 85.71% of its industry peers.
TRX had an Average Return On Invested Capital over the past 3 years of 8.16%. This is in line with the industry average of 8.64%.
The 3 year average ROIC (8.16%) for TRX is below the current ROIC(9.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.08%
ROE 0.16%
ROIC 9.83%
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
TRX Yearly ROA, ROE, ROICTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

TRX has a Profit Margin (0.19%) which is in line with its industry peers.
TRX has a Operating Margin of 22.46%. This is in the better half of the industry: TRX outperforms 77.92% of its industry peers.
Looking at the Gross Margin, with a value of 39.46%, TRX belongs to the top of the industry, outperforming 81.17% of the companies in the same industry.
Industry RankSector Rank
OM 22.46%
PM (TTM) 0.19%
GM 39.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRX Yearly Profit, Operating, Gross MarginsTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TRX is still creating some value.
The number of shares outstanding for TRX has been increased compared to 1 year ago.
Compared to 5 years ago, TRX has more shares outstanding
The debt/assets ratio for TRX is higher compared to a year ago.
TRX Yearly Shares OutstandingTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TRX Yearly Total Debt VS Total AssetsTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

TRX has an Altman-Z score of 0.08. This is a bad value and indicates that TRX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.08, TRX is not doing good in the industry: 81.17% of the companies in the same industry are doing better.
TRX has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
TRX has a better Debt to Equity ratio (0.04) than 69.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 0.08
ROIC/WACC1.15
WACC8.58%
TRX Yearly LT Debt VS Equity VS FCFTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

TRX has a Current Ratio of 0.77. This is a bad value and indicates that TRX is not financially healthy enough and could expect problems in meeting its short term obligations.
TRX has a worse Current ratio (0.77) than 88.31% of its industry peers.
A Quick Ratio of 0.40 indicates that TRX may have some problems paying its short term obligations.
TRX has a worse Quick ratio (0.40) than 89.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.4
TRX Yearly Current Assets VS Current LiabilitesTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

TRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.18%.
The Revenue has grown by 26.48% in the past year. This is a very strong growth!
EPS 1Y (TTM)-98.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-230.3%
Revenue 1Y (TTM)26.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, TRX will show a very strong growth in Revenue. The Revenue will grow by 27.51% on average per year.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.85%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
TRX Yearly Revenue VS EstimatesTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 20M 40M 60M
TRX Yearly EPS VS EstimatesTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.02 -0.02 0.04 0.06

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

TRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 4.80, which indicates a rather cheap valuation of TRX.
TRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. TRX is cheaper than 97.40% of the companies in the same industry.
TRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.8
TRX Price Earnings VS Forward Price EarningsTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

81.82% of the companies in the same industry are more expensive than TRX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.46
TRX Per share dataTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRX GOLD CORP

NYSEARCA:TRX (5/13/2025, 8:04:00 PM)

After market: 0.3101 -0.01 (-1.62%)

0.3152

+0.01 (+2.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)07-10 2025-07-10/amc
Inst Owners2.17%
Inst Owner Change5.28%
Ins Owners1.22%
Ins Owner ChangeN/A
Market Cap88.98M
Analysts80
Price Target1.22 (287.06%)
Short Float %0.03%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-149.5%
Min EPS beat(2)-199.01%
Max EPS beat(2)-100%
EPS beat(4)0
Avg EPS beat(4)-137.13%
Min EPS beat(4)-199.01%
Max EPS beat(4)-50.49%
EPS beat(8)0
Avg EPS beat(8)-118.56%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-21.19%
Min Revenue beat(2)-34.44%
Max Revenue beat(2)-7.94%
Revenue beat(4)0
Avg Revenue beat(4)-22.05%
Min Revenue beat(4)-34.44%
Max Revenue beat(4)-7.94%
Revenue beat(8)0
Avg Revenue beat(8)-20.48%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-18.09%
Revenue NQ rev (3m)-18.09%
Revenue NY rev (1m)-10.19%
Revenue NY rev (3m)-10.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.8
P/S 1.96
P/FCF N/A
P/OCF 6.57
P/B 1.63
P/tB 1.63
EV/EBITDA 6.46
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY20.83%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY15.23%
SpS0.16
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.08%
ROE 0.16%
ROCE 12.44%
ROIC 9.83%
ROICexc 10.74%
ROICexgc 10.74%
OM 22.46%
PM (TTM) 0.19%
GM 39.46%
FCFM N/A
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
ROICexc(3y)9.9%
ROICexc(5y)N/A
ROICexgc(3y)10.18%
ROICexgc(5y)N/A
ROCE(3y)10.33%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 0.16
Cap/Depr 498.66%
Cap/Sales 31.09%
Interest Coverage 250
Cash Conversion 104.03%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.4
Altman-Z 0.08
F-Score4
WACC8.58%
ROIC/WACC1.15
Cap/Depr(3y)4701.66%
Cap/Depr(5y)4096.58%
Cap/Sales(3y)58.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-230.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.07%
Revenue Next Year28.85%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1622.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.23%
OCF growth 3YN/A
OCF growth 5YN/A